Following the approval of Onpattro in 2018 and the global deployment of COVID-19 mRNA vaccines in 2020, lipid nanoparticles (LNPs) have emerged as key carriers for drug delivery, genome editing, and biologics. At TCG Lifesciences (TCGLS), with around 10 years of lipid chemistry experience, we have the following capabilities and service offerings.
Our Core Capabilities
TCGLS supports synthesis of diverse lipid classes including: